| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.23 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |